Clinical Trial Update: Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem

View source ↗

Summary

A completed, prospective single-center long-term observational update on the SL-PLUS MIA hip stem used in primary total hip arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Drugs mentioned

• SL-PLUS MIA Stem

Snippet

Sponsor: Smith & Nephew Orthopaedics AG | Conditions: Primary Total Hip Arthroplasty | Status: COMPLETED